DEEJ(SZ:000423)2023-03-24 16:00Financial Performance - The company's operating revenue for 2022 was CNY 4,041,818,347.54, representing a 5.01% increase from CNY 3,848,985,686.56 in 2021[12]. - The net profit attributable to shareholders for 2022 was CNY 779,998,116.10, a significant increase of 77.10% compared to CNY 440,439,963.60 in 2021[12]. - The basic earnings per share for 2022 was CNY 1.21, up 77.94% from CNY 0.68 in 2021[12]. - The total assets at the end of 2022 amounted to CNY 12,631,382,359.34, an increase of 8.63% from CNY 11,628,031,898.88 at the end of 2021[12]. - The net profit after deducting non-recurring gains and losses for 2022 was CNY 699,829,938.05, an increase of 98.60% from CNY 352,383,752.92 in 2021[12]. - The company reported a net profit of CNY 267,099,762.61 in Q4 2022, with a net cash flow from operating activities of CNY 856,590,701.17[15]. - The company achieved a weighted average return on equity of 7.68% in 2022, up from 4.46% in 2021[12]. - The company reported a total of ¥4,640,000,000.00 in new purchases of trading financial assets during the reporting period, with a total of ¥5,240,000,000.00 sold[46]. - The company reported a total revenue of 1.2 billion RMB for the fiscal year 2022, representing a year-over-year increase of 15%[124]. Cash Flow and Investments - The net cash flow from operating activities for 2022 was CNY 2,144,878,185.39, a decrease of 23.42% from CNY 2,800,902,528.25 in 2021[12]. - Cash and cash equivalents increased by 42.48% to ¥2,296,636,668.76[42]. - Investment activities generated a net cash flow of ¥589,507,998.15, a significant increase of 161.24% compared to the previous year[42]. - The company has a total of 30,000,000 CNY in principal guaranteed floating income products with an actual profit of 561.38 CNY[121]. - The company has entrusted 464,000 million RMB in bank wealth management products, with an unexpired balance of 185,000 million RMB[120]. Product Development and Market Strategy - The company has launched new products such as "Peach Blossom Princess" Ejiao cake and "Dong'e Ejiao" powder, targeting high-end female consumers and younger demographics[19][20]. - The company is focusing on expanding its market presence and product offerings in response to the growing demand for traditional Chinese medicine[18]. - The company is actively pursuing new product development and technological advancements to enhance its product offerings and market competitiveness[68]. - The company plans to enhance product differentiation and quality research, aiming to build competitive barriers and expand into multiple product categories[52]. - The company is considering strategic acquisitions to enhance its market position, with a budget of 500 million RMB allocated for potential deals[124]. Research and Development - The company is actively involved in research projects, including the clinical value assessment of Ejiao in treating cancer-related fatigue, which has shown significant improvement in patients' quality of life[21]. - The company has ongoing R&D projects aimed at developing traditional Chinese medicine products and health products, with significant clinical research backing[38]. - The company invested 200 million RMB in R&D for new technologies aimed at enhancing product efficacy and user experience[125]. - Research and development expenses decreased to ¥137,705,813.17 in 2022 from ¥147,749,402.42 in 2021, a decline of 6.9%[165]. Governance and Management - The company adheres to strict governance practices, ensuring compliance with relevant laws and regulations, and maintaining independence from its controlling shareholder[56][59]. - The company has established a reasonable mechanism for selecting its management team, ensuring clear responsibilities and accountability[58]. - The company has maintained a stable board of directors, with all current members serving until June 28, 2024[61]. - The company has conducted multiple investor communications, discussing overall business conditions, product positioning, and marketing strategies[55]. - The company reported a significant leadership change with the resignation of former Chairman and CEO Gao Dengfeng on February 20, 2023, due to work-related reasons[62]. Environmental and Social Responsibility - The company invested 5.26 million yuan in environmental governance and protection in 2022, with water resource tax expenditures amounting to 2.1529 million yuan[105]. - The company generated 3.731 million kWh of solar power in 2022, accounting for 16.07% of the total electricity consumption in the industrial park, resulting in a reduction of 3,720 tons of CO2 emissions[105]. - The company has a 100% monitoring rate, compliance rate, and disclosure rate for wastewater, waste gas, and noise monitoring[105]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[107]. Shareholder Information - The total number of shares held by Liu Guangli, a supervisor, increased by 900 shares during the reporting period[62]. - The total number of shares outstanding remained at 654,021,537, with no changes in shareholder structure[133]. - The largest shareholder, China Resources Dong'e Ejiao Co., Ltd., holds 151,351,731 shares, accounting for 23.14% of the total share capital[137]. - The company distributed dividends totaling ¥196,206,407.94 to shareholders during the year[175]. Financial Reporting and Compliance - The audit opinion issued by Ernst & Young was a standard unqualified opinion, confirming that the financial statements fairly reflect the company's financial position[146]. - The financial statements were approved by the board of directors on March 23, 2023, ensuring compliance with accounting standards[178]. - The company has maintained effective internal controls over revenue recognition and accounts receivable management[150]. - The company has not reported any penalties from regulatory authorities for its directors and supervisors in the last three years[73].